Chronic inflammation is the root driver of most modern diseases — from arthritis and cardiovascular disease to autoimmune conditions and metabolic syndrome. Red light therapy (RLT) is one of the most evidence-backed non-pharmacological tools for reducing systemic and local inflammation.

How Red Light Reduces Inflammation

The anti-inflammatory effects of red and near-infrared light operate through multiple pathways:

  • Reduction of pro-inflammatory cytokines — RLT consistently reduces TNF-α, IL-1β, IL-6, and IL-8 in both animal and human studies
  • Upregulation of anti-inflammatory cytokines — IL-10 and TGF-β levels increase, shifting the inflammatory balance
  • Reduction of COX-2 expression — The same enzyme targeted by ibuprofen and NSAIDs
  • Improved mitochondrial function — Reduces oxidative stress and reactive oxygen species (ROS), which trigger inflammatory cascades
  • NF-κB pathway modulation — RLT can inhibit the master inflammatory regulator NF-κB at moderate doses
  • Mast cell stabilization — Fewer histamine releases mean reduced inflammatory signaling
Biphasic Dose Response

RLT exhibits a "biphasic dose response" — low-to-moderate doses are anti-inflammatory, while very high doses can be pro-inflammatory. This is why proper dosing (10–20 minute sessions, not 60+ minutes) is important. More is not always better.

Conditions with Strong Evidence

  • Osteoarthritis — Cochrane-reviewed evidence for pain and inflammation reduction
  • Rheumatoid arthritis — Reduced morning stiffness and joint inflammation
  • Tendinopathy — Reduced inflammatory damage in tendons (Achilles, rotator cuff)
  • Sports injuries — Acute inflammation from strains and sprains
  • Inflammatory skin conditions — Psoriasis, rosacea, eczema
  • Post-surgical inflammation — Used clinically to reduce recovery time

Systemic vs. Local Anti-Inflammatory Effects

An important distinction: RLT applied to a local area produces both local and systemic effects. The reduction in inflammatory cytokines at the treatment site enters circulation and can affect inflammatory markers body-wide. Full-body panel use is therefore valuable for people with systemic inflammatory conditions (RA, psoriatic arthritis, Crohn's, etc.).

How to Use RLT for Inflammation

For acute inflammation (injury, flare-up): daily sessions for 5–7 days, 10–15 minutes per area. For chronic inflammation management: 3–5 sessions per week, long-term. Use 660 nm for surface inflammation, 850 nm for deep-tissue inflammation. Combination devices are ideal.